JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

BSX

100.2

-0.77%↓

Search

Thermo Fisher Scientific Inc

Closed

SectorHealthcare

558.41 0.1

Overview

Share price change

24h

Current

Min

553.91

Max

571.44

Key metrics

By Trading Economics

Income

6M

1.6B

Sales

267M

11B

P/E

Sector Avg

33.105

37.003

EPS

5.79

Dividend yield

0.29

Profit margin

14.575

Employees

125,000

EBITDA

-164M

2.6B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+10.37% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.29%

2.25%

Next Ex Dividend date

12 gru 2025

Market Stats

By TradingEconomics

Market Cap

11B

216B

Previous open

558.31

Previous close

558.41

News Sentiment

By Acuity

34%

66%

74 / 373 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Thermo Fisher Scientific Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 paź 2025, 10:51 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 billion

23 paź 2025, 20:49 UTC

Earnings

Correction to Thermo Fisher Article on Oct. 22

22 paź 2025, 10:28 UTC

Earnings

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

23 lip 2025, 10:33 UTC

Earnings

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 cze 2025, 21:19 UTC

Acquisitions, Mergers, Takeovers

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

29 paź 2025, 10:06 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher: Clario Provides Endpoint Data Solutions for Clinical Trials >TMO

29 paź 2025, 10:05 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher: Claro Deal Includes Potential Additional Earnout, Other Payments >TMO

29 paź 2025, 10:05 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher to Buy Clario From Group Led by Astorg and Nordic Cap, Novo Holding, Cinven >TMO

29 paź 2025, 10:04 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Scientific to Pay $8.875 Billion at Closing for Clario Holdings >TMO

29 paź 2025, 10:00 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Scientific to Acquire Clario Holdings >TMO

22 paź 2025, 10:01 UTC

Earnings

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

22 paź 2025, 10:00 UTC

Earnings

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

22 paź 2025, 10:00 UTC

Earnings

Thermo Fisher 3Q Adj EPS $5.79 >TMO

22 paź 2025, 10:00 UTC

Earnings

Thermo Fisher 3Q Rev $11.12B >TMO

22 paź 2025, 10:00 UTC

Earnings

Thermo Fisher 3Q Net $1.62B >TMO

22 paź 2025, 10:00 UTC

Earnings

Thermo Fisher 3Q EPS $4.27 >TMO

2 wrz 2025, 12:15 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2 wrz 2025, 12:08 UTC

Acquisitions, Mergers, Takeovers

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2 wrz 2025, 12:08 UTC

Acquisitions, Mergers, Takeovers

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2 wrz 2025, 12:04 UTC

Acquisitions, Mergers, Takeovers

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2 wrz 2025, 12:03 UTC

Acquisitions, Mergers, Takeovers

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2 wrz 2025, 12:03 UTC

Acquisitions, Mergers, Takeovers

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2 wrz 2025, 12:00 UTC

Acquisitions, Mergers, Takeovers

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23 lip 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 lip 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 lip 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Net $1.62B >TMO

23 lip 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q EPS $4.28 >TMO

23 lip 2025, 10:00 UTC

Earnings

Thermo Fisher 2Q Rev $10.85B >TMO

14 lip 2025, 16:12 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 lip 2025, 15:06 UTC

Acquisitions, Mergers, Takeovers

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

Peer Comparison

Price change

Thermo Fisher Scientific Inc Forecast

Price Target

By TipRanks

10.37% upside

12 Months Forecast

Average 615.44 USD  10.37%

High 675 USD

Low 561 USD

Based on 20 Wall Street analysts offering 12 month price targets forThermo Fisher Scientific Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

20 ratings

17

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

406.5 / 417.79Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

74 / 373 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat